世界の膵臓がん診断装置市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pancreatic Cancer Diagnostic Devices Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5288 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、膵臓がん診断装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イメージング、腫瘍バイオマーカー、生検、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・膵臓がん診断装置の市場動向 ・企業の競争状況、市場シェア ・膵臓がん診断装置の種類別市場規模と予測2016-2027（イメージング、腫瘍バイオマーカー、生検、その他） ・膵臓がん診断装置の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・膵臓がん診断装置の北米市場規模2016-2027（アメリカ、カナダ） ・膵臓がん診断装置の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・膵臓がん診断装置のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・膵臓がん診断装置の中南米市場規模2016-2027（メキシコ、ブラジル） ・膵臓がん診断装置の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、GE Healthcare、Siemens、BD、Philips Healthcare、Hitachi Medical、Danaher、Abbott、Canon Medical Systems、Myriad Genetics、Qiagen、Asuragen、BioMarker Strategies） ・結論

Imaging tests that create pictures of your internal organs. These tests help your doctors visualize your internal organs, including the pancreas. Techniques used to diagnose pancreatic cancer include ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) and, sometimes, positron emission tomography (PET) scans.

Market Analysis and Insights: Global Pancreatic Cancer Diagnostic Devices Market
The global Pancreatic Cancer Diagnostic Devices market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pancreatic Cancer Diagnostic Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pancreatic Cancer Diagnostic Devices market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pancreatic Cancer Diagnostic Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pancreatic Cancer Diagnostic Devices market.

Global Pancreatic Cancer Diagnostic Devices Scope and Market Size
Pancreatic Cancer Diagnostic Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Cancer Diagnostic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Imaging
Tumor Biomarker
Biopsy
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
GE Healthcare
Siemens
BD
Philips Healthcare
Hitachi Medical
Danaher
Abbott
Canon Medical Systems
Myriad Genetics
Qiagen
Asuragen
BioMarker Strategies

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Cancer Diagnostic Devices Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Imaging
1.2.3 Tumor Biomarker
1.2.4 Biopsy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pancreatic Cancer Diagnostic Devices Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pancreatic Cancer Diagnostic Devices Market Perspective (2016-2027)
2.2 Pancreatic Cancer Diagnostic Devices Growth Trends by Regions
2.2.1 Pancreatic Cancer Diagnostic Devices Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pancreatic Cancer Diagnostic Devices Historic Market Share by Regions (2016-2021)
2.2.3 Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Regions (2022-2027)
2.3 Pancreatic Cancer Diagnostic Devices Industry Dynamic
2.3.1 Pancreatic Cancer Diagnostic Devices Market Trends
2.3.2 Pancreatic Cancer Diagnostic Devices Market Drivers
2.3.3 Pancreatic Cancer Diagnostic Devices Market Challenges
2.3.4 Pancreatic Cancer Diagnostic Devices Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Cancer Diagnostic Devices Players by Revenue
3.1.1 Global Top Pancreatic Cancer Diagnostic Devices Players by Revenue (2016-2021)
3.1.2 Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Players (2016-2021)
3.2 Global Pancreatic Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Cancer Diagnostic Devices Revenue
3.4 Global Pancreatic Cancer Diagnostic Devices Market Concentration Ratio
3.4.1 Global Pancreatic Cancer Diagnostic Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Diagnostic Devices Revenue in 2020
3.5 Pancreatic Cancer Diagnostic Devices Key Players Head office and Area Served
3.6 Key Players Pancreatic Cancer Diagnostic Devices Product Solution and Service
3.7 Date of Enter into Pancreatic Cancer Diagnostic Devices Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pancreatic Cancer Diagnostic Devices Breakdown Data by Type
4.1 Global Pancreatic Cancer Diagnostic Devices Historic Market Size by Type (2016-2021)
4.2 Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Type (2022-2027)

5 Pancreatic Cancer Diagnostic Devices Breakdown Data by Application
5.1 Global Pancreatic Cancer Diagnostic Devices Historic Market Size by Application (2016-2021)
5.2 Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pancreatic Cancer Diagnostic Devices Market Size (2016-2027)
6.2 North America Pancreatic Cancer Diagnostic Devices Market Size by Type
6.2.1 North America Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021)
6.2.2 North America Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027)
6.2.3 North America Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2027)
6.3 North America Pancreatic Cancer Diagnostic Devices Market Size by Application
6.3.1 North America Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021)
6.3.2 North America Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027)
6.3.3 North America Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2027)
6.4 North America Pancreatic Cancer Diagnostic Devices Market Size by Country
6.4.1 North America Pancreatic Cancer Diagnostic Devices Market Size by Country (2016-2021)
6.4.2 North America Pancreatic Cancer Diagnostic Devices Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pancreatic Cancer Diagnostic Devices Market Size (2016-2027)
7.2 Europe Pancreatic Cancer Diagnostic Devices Market Size by Type
7.2.1 Europe Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021)
7.2.2 Europe Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027)
7.2.3 Europe Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2027)
7.3 Europe Pancreatic Cancer Diagnostic Devices Market Size by Application
7.3.1 Europe Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021)
7.3.2 Europe Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027)
7.3.3 Europe Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2027)
7.4 Europe Pancreatic Cancer Diagnostic Devices Market Size by Country
7.4.1 Europe Pancreatic Cancer Diagnostic Devices Market Size by Country (2016-2021)
7.4.2 Europe Pancreatic Cancer Diagnostic Devices Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size (2016-2027)
8.2 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Type
8.2.1 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2027)
8.3 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Application
8.3.1 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2027)
8.4 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Region
8.4.1 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pancreatic Cancer Diagnostic Devices Market Size (2016-2027)
9.2 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type
9.2.1 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021)
9.2.2 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027)
9.2.3 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2027)
9.3 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application
9.3.1 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021)
9.3.2 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027)
9.3.3 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2027)
9.4 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country
9.4.1 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country (2016-2021)
9.4.2 Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size (2016-2027)
10.2 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Type
10.2.1 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2027)
10.3 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Application
10.3.1 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2027)
10.4 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Country
10.4.1 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Pancreatic Cancer Diagnostic Devices Introduction
11.1.4 Roche Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.1.5 Roche Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Pancreatic Cancer Diagnostic Devices Introduction
11.2.4 GE Healthcare Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.2.5 GE Healthcare Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Pancreatic Cancer Diagnostic Devices Introduction
11.3.4 Siemens Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.3.5 Siemens Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Pancreatic Cancer Diagnostic Devices Introduction
11.4.4 BD Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.4.5 BD Recent Development
11.5 Philips Healthcare
11.5.1 Philips Healthcare Company Details
11.5.2 Philips Healthcare Business Overview
11.5.3 Philips Healthcare Pancreatic Cancer Diagnostic Devices Introduction
11.5.4 Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.5.5 Philips Healthcare Recent Development
11.6 Hitachi Medical
11.6.1 Hitachi Medical Company Details
11.6.2 Hitachi Medical Business Overview
11.6.3 Hitachi Medical Pancreatic Cancer Diagnostic Devices Introduction
11.6.4 Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.6.5 Hitachi Medical Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Pancreatic Cancer Diagnostic Devices Introduction
11.7.4 Danaher Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.7.5 Danaher Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Pancreatic Cancer Diagnostic Devices Introduction
11.8.4 Abbott Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.8.5 Abbott Recent Development
11.9 Canon Medical Systems
11.9.1 Canon Medical Systems Company Details
11.9.2 Canon Medical Systems Business Overview
11.9.3 Canon Medical Systems Pancreatic Cancer Diagnostic Devices Introduction
11.9.4 Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.9.5 Canon Medical Systems Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Pancreatic Cancer Diagnostic Devices Introduction
11.10.4 Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.10.5 Myriad Genetics Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Pancreatic Cancer Diagnostic Devices Introduction
11.11.4 Qiagen Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.11.5 Qiagen Recent Development
11.12 Asuragen
11.12.1 Asuragen Company Details
11.12.2 Asuragen Business Overview
11.12.3 Asuragen Pancreatic Cancer Diagnostic Devices Introduction
11.12.4 Asuragen Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.12.5 Asuragen Recent Development
11.13 BioMarker Strategies
11.13.1 BioMarker Strategies Company Details
11.13.2 BioMarker Strategies Business Overview
11.13.3 BioMarker Strategies Pancreatic Cancer Diagnostic Devices Introduction
11.13.4 BioMarker Strategies Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
11.13.5 BioMarker Strategies Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pancreatic Cancer Diagnostic Devices Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Imaging
Table 3. Key Players of Tumor Biomarker
Table 4. Key Players of Biopsy
Table 5. Key Players of Others
Table 6. Global Pancreatic Cancer Diagnostic Devices Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pancreatic Cancer Diagnostic Devices Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pancreatic Cancer Diagnostic Devices Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pancreatic Cancer Diagnostic Devices Market Share by Regions (2016-2021)
Table 10. Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pancreatic Cancer Diagnostic Devices Market Share by Regions (2022-2027)
Table 12. Pancreatic Cancer Diagnostic Devices Market Trends
Table 13. Pancreatic Cancer Diagnostic Devices Market Drivers
Table 14. Pancreatic Cancer Diagnostic Devices Market Challenges
Table 15. Pancreatic Cancer Diagnostic Devices Market Restraints
Table 16. Global Pancreatic Cancer Diagnostic Devices Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pancreatic Cancer Diagnostic Devices Market Share by Players (2016-2021)
Table 18. Global Top Pancreatic Cancer Diagnostic Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Diagnostic Devices as of 2020)
Table 19. Ranking of Global Top Pancreatic Cancer Diagnostic Devices Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pancreatic Cancer Diagnostic Devices Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pancreatic Cancer Diagnostic Devices Product Solution and Service
Table 23. Date of Enter into Pancreatic Cancer Diagnostic Devices Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Type (2016-2021)
Table 27. Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pancreatic Cancer Diagnostic Devices Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Application (2016-2021)
Table 31. Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pancreatic Cancer Diagnostic Devices Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pancreatic Cancer Diagnostic Devices Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pancreatic Cancer Diagnostic Devices Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pancreatic Cancer Diagnostic Devices Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Pancreatic Cancer Diagnostic Devices Product
Table 66. Roche Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. GE Healthcare Company Details
Table 69. GE Healthcare Business Overview
Table 70. GE Healthcare Pancreatic Cancer Diagnostic Devices Product
Table 71. GE Healthcare Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 72. GE Healthcare Recent Development
Table 73. Siemens Company Details
Table 74. Siemens Business Overview
Table 75. Siemens Pancreatic Cancer Diagnostic Devices Product
Table 76. Siemens Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 77. Siemens Recent Development
Table 78. BD Company Details
Table 79. BD Business Overview
Table 80. BD Pancreatic Cancer Diagnostic Devices Product
Table 81. BD Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 82. BD Recent Development
Table 83. Philips Healthcare Company Details
Table 84. Philips Healthcare Business Overview
Table 85. Philips Healthcare Pancreatic Cancer Diagnostic Devices Product
Table 86. Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 87. Philips Healthcare Recent Development
Table 88. Hitachi Medical Company Details
Table 89. Hitachi Medical Business Overview
Table 90. Hitachi Medical Pancreatic Cancer Diagnostic Devices Product
Table 91. Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 92. Hitachi Medical Recent Development
Table 93. Danaher Company Details
Table 94. Danaher Business Overview
Table 95. Danaher Pancreatic Cancer Diagnostic Devices Product
Table 96. Danaher Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 97. Danaher Recent Development
Table 98. Abbott Company Details
Table 99. Abbott Business Overview
Table 100. Abbott Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 101. Abbott Recent Development
Table 102. Canon Medical Systems Company Details
Table 103. Canon Medical Systems Business Overview
Table 104. Canon Medical Systems Pancreatic Cancer Diagnostic Devices Product
Table 105. Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 106. Canon Medical Systems Recent Development
Table 107. Myriad Genetics Company Details
Table 108. Myriad Genetics Business Overview
Table 109. Myriad Genetics Pancreatic Cancer Diagnostic Devices Product
Table 110. Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 111. Myriad Genetics Recent Development
Table 112. Qiagen Company Details
Table 113. Qiagen Business Overview
Table 114. Qiagen Pancreatic Cancer Diagnostic Devices Product
Table 115. Qiagen Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 116. Qiagen Recent Development
Table 117. Asuragen Company Details
Table 118. Asuragen Business Overview
Table 119. Asuragen Pancreatic Cancer Diagnostic Devices Product
Table 120. Asuragen Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 121. Asuragen Recent Development
Table 122. BioMarker Strategies Company Details
Table 123. BioMarker Strategies Business Overview
Table 124. BioMarker Strategies Pancreatic Cancer Diagnostic Devices Product
Table 125. BioMarker Strategies Revenue in Pancreatic Cancer Diagnostic Devices Business (2016-2021) & (US$ Million)
Table 126. BioMarker Strategies Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Cancer Diagnostic Devices Market Share by Type: 2020 VS 2027
Figure 2. Imaging Features
Figure 3. Tumor Biomarker Features
Figure 4. Biopsy Features
Figure 5. Others Features
Figure 6. Global Pancreatic Cancer Diagnostic Devices Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Pancreatic Cancer Diagnostic Devices Report Years Considered
Figure 11. Global Pancreatic Cancer Diagnostic Devices Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pancreatic Cancer Diagnostic Devices Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pancreatic Cancer Diagnostic Devices Market Share by Regions: 2020 VS 2027
Figure 14. Global Pancreatic Cancer Diagnostic Devices Market Share by Regions (2022-2027)
Figure 15. Global Pancreatic Cancer Diagnostic Devices Market Share by Players in 2020
Figure 16. Global Top Pancreatic Cancer Diagnostic Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Diagnostic Devices as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pancreatic Cancer Diagnostic Devices Revenue in 2020
Figure 18. Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Type (2016-2021)
Figure 19. Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Type (2022-2027)
Figure 20. North America Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pancreatic Cancer Diagnostic Devices Market Share by Type (2016-2027)
Figure 22. North America Pancreatic Cancer Diagnostic Devices Market Share by Application (2016-2027)
Figure 23. North America Pancreatic Cancer Diagnostic Devices Market Share by Country (2016-2027)
Figure 24. United States Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pancreatic Cancer Diagnostic Devices Market Share by Type (2016-2027)
Figure 28. Europe Pancreatic Cancer Diagnostic Devices Market Share by Application (2016-2027)
Figure 29. Europe Pancreatic Cancer Diagnostic Devices Market Share by Country (2016-2027)
Figure 30. Germany Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Pancreatic Cancer Diagnostic Devices Market Share by Region (2016-2027)
Figure 40. China Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pancreatic Cancer Diagnostic Devices Market Share by Type (2016-2027)
Figure 48. Latin America Pancreatic Cancer Diagnostic Devices Market Share by Application (2016-2027)
Figure 49. Latin America Pancreatic Cancer Diagnostic Devices Market Share by Country (2016-2027)
Figure 50. Mexico Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Pancreatic Cancer Diagnostic Devices Market Share by Country (2016-2027)
Figure 56. Turkey Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 60. GE Healthcare Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 61. Siemens Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 62. BD Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 63. Philips Healthcare Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 64. Hitachi Medical Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 65. Danaher Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 66. Abbott Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 67. Canon Medical Systems Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 68. Myriad Genetics Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 69. Qiagen Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 70. Asuragen Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 71. BioMarker Strategies Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---